(1S,2R,4aS,5R,8aS)-1-formamido-1,4a-dimethyl-6-methylene-5-((E)-2-(2-oxo-2,5-dihydrofuran-3-yl)ethenyl)decahydronaphthalen-2-yl 4-nitrobenzoate

ID: ALA4473377

PubChem CID: 155536434

Max Phase: Preclinical

Molecular Formula: C27H30N2O7

Molecular Weight: 494.54

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C=C1CC[C@H]2[C@@](C)(CC[C@@H](OC(=O)c3ccc([N+](=O)[O-])cc3)[C@@]2(C)NC=O)[C@@H]1/C=C/C1=CCOC1=O

Standard InChI:  InChI=1S/C27H30N2O7/c1-17-4-11-22-26(2,21(17)10-7-19-13-15-35-24(19)31)14-12-23(27(22,3)28-16-30)36-25(32)18-5-8-20(9-6-18)29(33)34/h5-10,13,16,21-23H,1,4,11-12,14-15H2,2-3H3,(H,28,30)/b10-7+/t21-,22+,23-,26+,27+/m1/s1

Standard InChI Key:  FIOZAQKYNDVGNA-GTSVIRJVSA-N

Molfile:  

 
     RDKit          2D

 37 40  0  0  0  0  0  0  0  0999 V2000
   17.0702  -26.2574    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.6657  -25.5517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2568  -26.2548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0768  -25.5517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7821  -25.1472    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7821  -24.3300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0768  -23.9173    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5820  -25.9355    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   17.3674  -23.5087    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0766  -23.1001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7843  -22.6914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7841  -21.8742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4415  -21.3909    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1889  -20.6137    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.3716  -20.6139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1194  -21.3912    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2195  -21.6412    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.4910  -23.9235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3715  -25.1472    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3758  -24.3327    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6765  -23.9240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9684  -24.3252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9641  -25.1397    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6594  -26.9638    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8422  -26.9612    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.2538  -25.5438    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.5487  -25.1308    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8384  -25.5349    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5539  -24.3136    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.1370  -25.1210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4272  -25.5244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4216  -26.3425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1317  -26.7554    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8386  -26.3496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7119  -26.7475    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.0062  -26.3354    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.7078  -27.5647    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
 20  7  1  0
 19  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
 19  8  1  1
 20  9  1  6
  7 10  1  6
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 12  2  0
 13 17  2  0
  6 18  2  0
 19 20  1  0
 19  2  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23  2  1  0
  2  1  1  0
  2  3  1  1
  1 24  1  0
 24 25  2  0
 23 26  1  6
 26 27  1  0
 27 28  1  0
 27 29  2  0
 28 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 28  1  0
 32 35  1  0
 35 36  1  0
 35 37  2  0
M  CHG  2  35   1  36  -1
M  END

Alternative Forms

  1. Parent:

    ALA4473377

    ---

Associated Targets(Human)

HK2 Tchem Hexokinase type II (81 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

RAW264.7 (28094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 494.54Molecular Weight (Monoisotopic): 494.2053AlogP: 4.05#Rotatable Bonds: 7
Polar Surface Area: 124.84Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 13.57CX Basic pKa: CX LogP: 4.30CX LogD: 4.30
Aromatic Rings: 1Heavy Atoms: 36QED Weighted: 0.20Np Likeness Score: 2.05

References

1. Wang W, Wu Y, Yang K, Wu C, Tang R, Li H, Chen L..  (2019)  Synthesis of novel andrographolide beckmann rearrangement derivatives and evaluation of their HK2-related anti-inflammatory activities.,  173  [PMID:31009914] [10.1016/j.ejmech.2019.04.022]

Source